 HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Nov. 05, 2020 GLOBE NEWSWIRE -- Hutchison China MediTech Limited Chi-Med NasdaqAIM: HCM today announces that initial analysis of the first in human HMPL-689 Phase I dose escalation study will be presented as a poster at the upcoming 62nd American Society of Hematology ASH Annual Meeting and Exposition, taking place on December 5-8, 2020 virtually. 